Journal of Rheumatic Diseases

Cited by CrossRef (16)

  1. G. G. Song, Y. H. Lee. Comparative efficacy and safety of 15 and 30 mg upadacitinib administered to patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials. Z Rheumatol 2020;79:103
    https://doi.org/10.1007/s00393-019-0601-3
  2. ATUL DEODHAR. Mirror, Mirror, on the Wall, Which Is the Most Effective Biologic of All?. J Rheumatol 2018;45:449
    https://doi.org/10.3899/jrheum.171279
  3. Young Ho Lee, Gwan Gyu Song. Comparative Efficacy and Safety of Peficitinib 25, 50, 100, and 150 mg in Patients with Active Rheumatoid Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials. Clin Drug Investig 2020;40:65
    https://doi.org/10.1007/s40261-019-00863-9
  4. Ka Young Kim, Young Ho Lee. Anti-cyclic citrullinated peptide antibody in psoriatic arthritis: a meta-analysis of its frequency and association with clinical features. Z Rheumatol 2020;79:397
    https://doi.org/10.1007/s00393-019-0666-z
  5. Young Ho Lee. Strengths and Limitations of Meta-Analysis. Korean J Med 2019;94:391
    https://doi.org/10.3904/kjm.2019.94.5.391
  6. Y. H. Lee, G. G. Song. Comparison of the efficacy and safety of tofacitinib and filgotinib in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials. Z Rheumatol 2020;79:590
    https://doi.org/10.1007/s00393-019-00733-x
  7. S C Bae, Y H Lee. Alcohol intake and risk of systemic lupus erythematosus: a Mendelian randomization study. Lupus 2019;28:174
    https://doi.org/10.1177/0961203318817832
  8. Young Ho Lee, Gwan Gyu Song. Comparison of the efficacy and safety of tofacitinib and peficitinib in patients with active rheumatoid arthritis: A Bayesian network meta‐analysis of randomized controlled trials. Int J of Rheum Dis 2020;23:868
    https://doi.org/10.1111/1756-185X.13854
  9. S.-C. Bae, Y. H. Lee. Association between plasminogen activator inhibitor‑1 (PAI-1) 4G/5G polymorphism and circulating PAI-1 level in systemic lupus erythematosus and rheumatoid arthritis. Z Rheumatol 2020;79:312
    https://doi.org/10.1007/s00393-019-00689-y
  10. Young Ho Lee, Gwan Gyu Song. Relative efficacy and safety of tofacitinib, baricitinib, upadacitinib, and filgotinib in comparison to adalimumab in patients with active rheumatoid arthritis. Z Rheumatol 2020;79:785
    https://doi.org/10.1007/s00393-020-00750-1
  11. Young Ho Lee, Gwan Gyu Song. Relative efficacy and safety of Janus kinase inhibitors for the treatment of active psoriatic arthritis: a network meta-analysis. Z Rheumatol 2023;82:408
    https://doi.org/10.1007/s00393-021-01119-8
  12. Young Ho Lee, Gwan Gyu Song. Relative remission rates of Janus kinase inhibitors in comparison with adalimumab in patients with active rheumatoid arthritis: a network meta-analysis. Z Rheumatol 2024;83:88
    https://doi.org/10.1007/s00393-022-01165-w
  13. Young Ho Lee, Gwan Gyu Song. Comparative efficacy and safety of tofacitinib, baricitinib, upadacitinib, filgotinib and peficitinib as monotherapy for active rheumatoid arthritis. J Clin Pharm Ther 2020;45:674
    https://doi.org/10.1111/jcpt.13142
  14. Y. H. Lee, G. G. Song. Comparative efficacy and safety of secukinumab and ixekizumab in patients with active ankylosing spondylitis. Z Rheumatol 2021;80:776
    https://doi.org/10.1007/s00393-020-00837-9
  15. Gwan Gyu Song, Young Ho Lee. Comparison of the Efficacy and Safety of Tofacitinib and Apremilast in Patients with Active Psoriatic Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials. Clin Drug Investig 2019;39:421
    https://doi.org/10.1007/s40261-019-00765-w
  16. S -C Bae, Y H Lee. Association between CD40 polymorphisms and systemic lupus erythematosus and correlation between soluble CD40 and CD40 ligand levels in the disease: a meta-analysis. Lupus 2019;28:1452
    https://doi.org/10.1177/0961203319878822